The field of pharmaceutical drug development plays a critical role in modern healthcare, as it provides the medications and treatments that can alleviate human suffering and extend lives. However, it is essential that this industry operates within a strong moral compass, as the decisions made in drug development can have profound implications for patients, society and the healthcare system. This article delves into the moral dimensions of drug development, exploring the ethical considerations that guide the industry and the challenges it faces in maintaining its moral compass. We investigate the areas of informed consent, access to medicines, pricing and affordability and the pursuit of profit in the pharmaceutical sector. By examining these aspects, we aim to shed light on the complex interplay between ethics and drug development and the importance of ensuring that pharmaceutical companies prioritize the well-being of patients and society over financial gains.
HTML PDFShare this article
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
